We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Canopy Growth Corporation (CGC) Rises As Market Takes a Dip: Key Facts
Read MoreHide Full Article
In the latest market close, Canopy Growth Corporation (CGC - Free Report) reached $2.22, with a +0.91% movement compared to the previous day. The stock outperformed the S&P 500, which registered a daily loss of 0.29%. Meanwhile, the Dow experienced a drop of 0.32%, and the technology-dominated Nasdaq saw a decrease of 0.5%.
Heading into today, shares of the company had lost 22.54% over the past month, lagging the Medical sector's gain of 1.54% and the S&P 500's gain of 2.52% in that time.
The investment community will be closely monitoring the performance of Canopy Growth Corporation in its forthcoming earnings report. The company is predicted to post an EPS of -$0.48, indicating a 73.18% growth compared to the equivalent quarter last year. Alongside, our most recent consensus estimate is anticipating revenue of $47.69 million, indicating a 17.31% downward movement from the same quarter last year.
In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of -$3.31 per share and a revenue of $192.31 million, indicating changes of +18.27% and -21.34%, respectively, from the former year.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Canopy Growth Corporation. Such recent modifications usually signify the changing landscape of near-term business trends. Consequently, upward revisions in estimates express analysts' positivity towards the company's business operations and its ability to generate profits.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed an unchanged state. Canopy Growth Corporation currently has a Zacks Rank of #3 (Hold).
The Medical - Products industry is part of the Medical sector. At present, this industry carries a Zacks Industry Rank of 139, placing it within the bottom 45% of over 250 industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
To follow CGC in the coming trading sessions, be sure to utilize Zacks.com.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Canopy Growth Corporation (CGC) Rises As Market Takes a Dip: Key Facts
In the latest market close, Canopy Growth Corporation (CGC - Free Report) reached $2.22, with a +0.91% movement compared to the previous day. The stock outperformed the S&P 500, which registered a daily loss of 0.29%. Meanwhile, the Dow experienced a drop of 0.32%, and the technology-dominated Nasdaq saw a decrease of 0.5%.
Heading into today, shares of the company had lost 22.54% over the past month, lagging the Medical sector's gain of 1.54% and the S&P 500's gain of 2.52% in that time.
The investment community will be closely monitoring the performance of Canopy Growth Corporation in its forthcoming earnings report. The company is predicted to post an EPS of -$0.48, indicating a 73.18% growth compared to the equivalent quarter last year. Alongside, our most recent consensus estimate is anticipating revenue of $47.69 million, indicating a 17.31% downward movement from the same quarter last year.
In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of -$3.31 per share and a revenue of $192.31 million, indicating changes of +18.27% and -21.34%, respectively, from the former year.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Canopy Growth Corporation. Such recent modifications usually signify the changing landscape of near-term business trends. Consequently, upward revisions in estimates express analysts' positivity towards the company's business operations and its ability to generate profits.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed an unchanged state. Canopy Growth Corporation currently has a Zacks Rank of #3 (Hold).
The Medical - Products industry is part of the Medical sector. At present, this industry carries a Zacks Industry Rank of 139, placing it within the bottom 45% of over 250 industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
To follow CGC in the coming trading sessions, be sure to utilize Zacks.com.